Haas Jason

SEC Form 4 insider

LIGAND PHARMACEUTICALS INC ($LGND)

1 thesis · first seen Aug 14, 2026

Window	Theses	Resolved	Wins	Win rate	Avg return	Median return
1d	0	0	0	—	—	—
3d	1	1	1	100%	-1.0%	-1.0%
1w	1	1	1	100%	-2.8%	-2.8%
1m	1	1	1	100%	-3.4%	-3.4%
3m	1	1	0	0%	+7.4%	+7.4%
6m	0	0	0	—	—	—
1y	0	0	0	—	—	—

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$LGNDSEC Form 4bearish

Haas Jason · LIGAND PHARMACEUTICALS INC · 92d agono track record yet

Sold 7,138 @ $292.81 avg · $2,090,062 · 2026-08-12

Form 4: Haas Jason sold LGND

Haas Jason (Director at LIGAND PHARMACEUTICALS INC) reported an open-market sale of 7,138 shares of LGND at an average $292.81, roughly $2,090,062, in a Form 4 filed 2026-08-14.

At post $294.60Now $308.79+4.8% since postedas of Nov 13, 4:01 PM ET

1d—

3d-1.0%

1w-2.8%

1m-3.4%

3m+7.4%

6m—

1y—

View filing on SEC.gov →

End of results.